Navigation Links
ADHD linked to low maternal education, lone parents and welfare benefits
Date:6/1/2010

A major study of more than a million children has found strong links between receiving medication for attention deficit hyperactivity disorder (ADHD) and limited maternal education, single parent families and welfare benefits, according to the June issue of Acta Paediatrica

Swedish experts teamed up to carry out what they believe is the first study of risk factors for ADHD in a national cohort of school children, based on 1.16 million children on the country's Prescribed Drug Register.

"We identified 7,960 Swedish-born children, aged between six and 19, using a prescription for ADHD medication as our indicator of severe ADHD" explains lead author Professor Anders Hjern from the Centre for Health Equity Studies, a collaboration between the Karolinska Institutet and Stockholm University.

"We then tracked their records through other registers, using the unique ten digit reference number all Swedish residents are given at birth, to determine a number of other factors."

ADHD is a common, treatable childhood illness that can affect areas of the brain connected to problem solving, planning ahead, understanding others' actions and controlling impulses. The primary symptoms of the condition are hyperactivity, impulsivity and inattention.

"Genes are also known to play an important role in the development of ADHD and studies of identical twins show that they are very likely to exhibit the same ADHD traits" says Professor Hjern, who carried out the study when he was based at the National Board of Health and Welfare.

Key findings of the Swedish study include:

  • Boys were three times more likely to be on ADHD medication than girls, with medication use highest in boys aged between 10 and 15.

  • Women who had only received the most basic education were 130 per cent more likely to have a child on ADHD medication than women with university degrees.

  • Children were 54 per cent more likely to be on ADHD medication if they came from a single parent family rather than having both parents at home.

  • Coming from a family on welfare benefits increased the risk of ADHD medication by 135 per cent when compared with households not claiming benefits.

  • There were no statistically significant differences between the effects that socioeconomic factors had on boys or girls in the study.

When the researchers examined the total impact of the socioeconomic factors, they found that the impact was similar to that reported in twin studies.

"Our study showed that almost half of the cases could be explained by the socioeconomic factors included in our analysis, clearly demonstrating that these are potent predictors of ADHD-medication in Swedish schoolchildren" says Professor Hjern.

"There are several ways that family factors may influence ADHD. For example, low parental education is associated with general social disadvantage, a higher number of stress factors and a greater risk of childhood adversity.

"Lack of time and money are more common in single parent families, as are lack of social support and family conflict, including separation, divorce and parental absence.

"We believe that further research into ADHD should focus on the interaction between genes and environmental factors in order to determine the reasons why some children develop ADHD and how it could be prevented."


'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Agricultural Chemical Spray Linked to Birth Defect Risk
2. 3 brain diseases linked by toxic form of same neural protein
3. Bad Behavior as a Kid Linked to Early Death in Men
4. Sedation Linked to Longer Stay in ICU
5. Personal History Linked to Feelings of Betrayal
6. Improved air quality linked to fewer pediatric ear infections
7. Flame-Retardant Chemical Linked to Conception Problems
8. Common antidepressant drugs linked to lactation difficulties in moms
9. Vitamin D Linked to Survival in Lymphoma Patients
10. Poop dermatitis linked to fashionable toilet seats, harsh chemicals
11. Self-Image Linked to Activity in Frontal Lobe of Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Rollerblade®, the worldwide ... (ABT), an innovative braking system that allows skaters of all levels to stop ... the biggest concerns of beginner and intermediate skaters – learning how to brake ...
(Date:1/18/2017)... ... 18, 2017 , ... Floundering on New Year’s resolutions? Need an excuse to ... a reset. The U.S. Apple Association agrees and recommends starting each day with ... contribute to heart disease. , The U.S. Apple Association – which represents apple growers ...
(Date:1/17/2017)... ... ... Anesthesia Progress – Everyone wants less pain during dental surgery, but ... patient. Dentists have several general anesthesia alternatives and finding the right option can result ... College in Tokyo, Japan wanted to find out which anesthetic was the better choice ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... of difference. Eden Activewear is a stand-out company for several differences from other ... and only manufacture on demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, to help those who ... powerfully uplifting interview with medical expert and prolific author, Dr. Bernie Siegel. ... tough times, Dr. Bernie Siegel energizes listeners to live life with intrigue, magic ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Israel , January 17, 2017 Management ... TyrNovo, Ltd.   KIT-302 Development On Track For ... FDA in Q1 2017   ... Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; ... update call on Monday, January 23 rd at 8:30am Eastern Time to ...
(Date:1/17/2017)... 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... enrolled in a Phase 3 clinical trial comparing the ... (BSC) in the prevention of hepatic veno-occlusive disease (VOD) ... transplant (HSCT) who are at high risk or at ... trial will be conducted across approximately 100 medical centers ...
(Date:1/17/2017)... Calif. , Jan. 17, 2017  Edwards Lifesciences ... in patient-focused innovations for structural heart disease and critical ... the quarter ended December 31, 2016 after the market ... a conference call at 5:00 p.m. ET that day ... the conference call, dial (877) 407-8037 or (201) 689-8037.  ...
Breaking Medicine Technology: